CD33 and breast cancer: Dual-staining for sCLU and CD68 or CD33 indicated that sCLU was primarily expressed in CD68+ mature macrophages and not in immature CD33+ myeloid cells, as shown in a representative tumor tissue from a breast cancer patient in Fig. 7.